| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 86 | 506 | 496 | 485 | 487 | 485 | 965 |
| Total Income - EUR | 0 | 0 | 0 | 86 | 506 | 496 | 485 | 487 | 485 | 965 |
| Total Expenses - EUR | 522 | 853 | 739 | 966 | 584 | 264 | 466 | 461 | 302 | 675 |
| Gross Profit/Loss - EUR | -522 | -853 | -739 | -880 | -78 | 233 | 19 | 26 | 183 | 290 |
| Net Profit/Loss - EUR | -522 | -853 | -739 | -883 | -93 | 218 | 4 | 12 | 154 | 243 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Pasca Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.552 | 9.398 | 8.903 | 8.190 | 7.686 | 7.540 | 7.159 | 6.962 | 6.834 | 6.309 |
| Current Assets | 5.031 | 1.552 | 2.261 | 1.893 | 2.128 | 1.279 | 1.468 | 1.195 | 1.455 | 1.263 |
| Inventories | 1.541 | 1.031 | 1.014 | 995 | 976 | 0 | 936 | 939 | 936 | 0 |
| Receivables | 3.025 | 6 | 15 | 11 | 0 | 958 | 0 | 0 | 0 | 0 |
| Cash | 466 | 515 | 1.232 | 886 | 1.151 | 321 | 532 | 256 | 519 | 1.263 |
| Shareholders Funds | -17.976 | -22.515 | -22.873 | -23.336 | -22.977 | -22.323 | -21.824 | -21.880 | -21.660 | 6.445 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 33.472 | 33.465 | 34.037 | 33.418 | 32.790 | 31.143 | 30.451 | 30.037 | 29.949 | 1.128 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4673 - 4673" | |||||||||
| CAEN Financial Year |
4634
|
|||||||||
Comments - Dr. Pasca Company Srl